School of Medicine

Showing 1-4 of 4 Results

  • Vali Barsan

    Vali Barsan

    Fellow in Pediatrics - Hematology & Oncology

    Current Research and Scholarly Interests Adoptive T cell immunotherapy entails engineering immune cells to recognize cancer-specific antigens and target them for destruction. Barriers to efficacy can arise from both tumor antigen related as well as T cell related features. I am interested developing noninvasive molecular tools that enable us to understanding these relationships to improve the clinical application and development of cellular immunotherapeutics.

  • Adrienne H. Long, MD, PhD

    Adrienne H. Long, MD, PhD

    Fellow in Pediatrics - Hematology & Oncology

    Bio Adrienne Long, MD, PhD is a fellow in the Division of Pediatric Hematology and Oncology at the Lucile Packard Children's Hospital Stanford. Dr. Long attend Northwestern University, where she earned both a BS in biomedical engineering and her MD. Driven by a clinical interest in pediatric oncology and the recognized need for novel treatment approaches, she chose to pursue a PhD studying CAR T cells at the National Institutes of Health (NIH) with Dr. Crystal Mackall. Her thesis work was the first to identify T cell exhaustion as a critical factor limiting efficacy of CAR T cell therapies (Long et al., Nature Medicine, 2015). She also worked on novel methods to enhance CAR T cell therapies for pediatric solid tumors (Long/Highfill et al., Cancer Immunology Research, 2016). Dr. Long went on to complete her pediatrics residency training at Boston Children’s Hospital, where she continued her research in cancer immunology with Dr. Nicholas Haining – this time focusing on strategies to enhance antigen presentation to augment PD1 blockade (Long et al. presented at the Keystone Symposium on Cancer Immunotherapy, 2019). She remains dedicated to a career as a physician-scientist focused on developing novel immunotherapies for children with cancer.

  • Stephanie Melissa Smith

    Stephanie Melissa Smith

    Fellow in Pediatrics - Hematology & Oncology

    Current Research and Scholarly Interests I am involved with clinical research related to cancer survivorship, with a particular focus on late effects of childhood cancer treatments. My current research relates to the use of BCR-ABL tyrosine kinase inhibitors for CML and Ph+ ALL, as little is known about the long-term and late effects of these therapies in young people. I am also collaborating with several others to develop an online cancer survivorship course for primary care physicians.